Nerve blocks may cut opioid use after Open-Heart surgery

NCT ID NCT04985500

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study compares two types of nerve blocks—erector spinae plane (ESP) block and pecto-intercostal fascial (PIF) block—against standard care for controlling pain after heart surgery through the breastbone. About 225 adults aged 18–85 having planned cardiac surgery with a sternotomy will be randomly assigned to receive one of the blocks or no block. The main goal is to see if the blocks reduce opioid painkiller use and pain scores in the first 72 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If successful, these nerve blocks could become a standard way to control pain after heart surgery, reducing the need for opioids.
What could go wrong
This is an early-phase trial with a modest number of participants. The blocks may not provide significant pain relief over standard care, and there is a small risk of local anesthetic toxicity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mount Sinai Morningside Hospital

    New York, New York, 10025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.